Breast cancer related lymphedema in patients with different loco-regional treatments.
Identifieur interne : 002141 ( PubMed/Checkpoint ); précédent : 002140; suivant : 002142Breast cancer related lymphedema in patients with different loco-regional treatments.
Auteurs : Beyza Ozcinar [Turquie] ; Sertac Ata Guler ; Nazmiye Kocaman ; Mine Ozkan ; Bahadir M. Gulluoglu ; Vahit OzmenSource :
- Breast (Edinburgh, Scotland) [ 1532-3080 ] ; 2012.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Biopsie de noeud lymphatique sentinelle (), Biopsie de noeud lymphatique sentinelle (effets indésirables), Facteurs de risque, Femelle, Humains, Incidence, Indice de gravité médicale, Jeune adulte, Lymphadénectomie (), Lymphadénectomie (effets indésirables), Lymphoedème (anatomopathologie), Lymphoedème (épidémiologie), Lymphoedème (étiologie), Santé des femmes, Stade de la tumeur, Sujet âgé, Sujet âgé de 80 ans ou plus, Survie sans rechute, Tumeurs du sein (), Tumeurs du sein (anatomopathologie), Tumeurs du sein (épidémiologie), Turquie, Études de cohortes, Études de suivi, Études prospectives.
- MESH :
- anatomopathologie : Lymphoedème, Tumeurs du sein.
- effets indésirables : Biopsie de noeud lymphatique sentinelle, Lymphadénectomie.
- épidémiologie : Lymphoedème, Tumeurs du sein.
- étiologie : Lymphoedème.
- Adulte, Adulte d'âge moyen, Biopsie de noeud lymphatique sentinelle, Facteurs de risque, Femelle, Humains, Incidence, Indice de gravité médicale, Jeune adulte, Lymphadénectomie, Santé des femmes, Stade de la tumeur, Sujet âgé, Sujet âgé de 80 ans ou plus, Survie sans rechute, Tumeurs du sein, Turquie, Études de cohortes, Études de suivi, Études prospectives.
- Wicri :
- geographic : Turquie.
English descriptors
- KwdEn :
- Adult, Aged, Aged, 80 and over, Breast Neoplasms (epidemiology), Breast Neoplasms (pathology), Breast Neoplasms (surgery), Cohort Studies, Disease-Free Survival, Female, Follow-Up Studies, Humans, Incidence, Lymph Node Excision (adverse effects), Lymph Node Excision (statistics & numerical data), Lymphedema (epidemiology), Lymphedema (etiology), Lymphedema (pathology), Middle Aged, Neoplasm Staging, Prospective Studies, Risk Factors, Sentinel Lymph Node Biopsy (adverse effects), Sentinel Lymph Node Biopsy (statistics & numerical data), Severity of Illness Index, Turkey, Women's Health, Young Adult.
- MESH :
- geographic : Turkey.
- adverse effects : Lymph Node Excision, Sentinel Lymph Node Biopsy.
- epidemiology : Breast Neoplasms, Lymphedema.
- etiology : Lymphedema.
- pathology : Breast Neoplasms, Lymphedema.
- statistics & numerical data : Lymph Node Excision, Sentinel Lymph Node Biopsy.
- surgery : Breast Neoplasms.
- Adult, Aged, Aged, 80 and over, Cohort Studies, Disease-Free Survival, Female, Follow-Up Studies, Humans, Incidence, Middle Aged, Neoplasm Staging, Prospective Studies, Risk Factors, Severity of Illness Index, Women's Health, Young Adult.
Abstract
Lymphedema, a sequela of breast cancer and breast cancer therapy, changes functional abilities and may affect a patient's psychosocial adjustment and overall quality of life. Aim of this prospective observational study was to determine the rate of mid-term and late time period lymphedema in breast cancer patients with different loco-regional treatments, and factors associated with lymphedema.
DOI: 10.1016/j.breast.2012.03.002
PubMed: 22460058
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:22460058Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Breast cancer related lymphedema in patients with different loco-regional treatments.</title><author><name sortKey="Ozcinar, Beyza" sort="Ozcinar, Beyza" uniqKey="Ozcinar B" first="Beyza" last="Ozcinar">Beyza Ozcinar</name><affiliation wicri:level="1"><nlm:affiliation>Istanbul University, Istanbul Medical Faculty, General Surgery Department, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Istanbul University, Istanbul Medical Faculty, General Surgery Department, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Guler, Sertac Ata" sort="Guler, Sertac Ata" uniqKey="Guler S" first="Sertac Ata" last="Guler">Sertac Ata Guler</name></author><author><name sortKey="Kocaman, Nazmiye" sort="Kocaman, Nazmiye" uniqKey="Kocaman N" first="Nazmiye" last="Kocaman">Nazmiye Kocaman</name></author><author><name sortKey="Ozkan, Mine" sort="Ozkan, Mine" uniqKey="Ozkan M" first="Mine" last="Ozkan">Mine Ozkan</name></author><author><name sortKey="Gulluoglu, Bahadir M" sort="Gulluoglu, Bahadir M" uniqKey="Gulluoglu B" first="Bahadir M" last="Gulluoglu">Bahadir M. Gulluoglu</name></author><author><name sortKey="Ozmen, Vahit" sort="Ozmen, Vahit" uniqKey="Ozmen V" first="Vahit" last="Ozmen">Vahit Ozmen</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2012">2012</date><idno type="RBID">pubmed:22460058</idno><idno type="pmid">22460058</idno><idno type="doi">10.1016/j.breast.2012.03.002</idno><idno type="wicri:Area/PubMed/Corpus">002193</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002193</idno><idno type="wicri:Area/PubMed/Curation">002193</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002193</idno><idno type="wicri:Area/PubMed/Checkpoint">002193</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002193</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Breast cancer related lymphedema in patients with different loco-regional treatments.</title><author><name sortKey="Ozcinar, Beyza" sort="Ozcinar, Beyza" uniqKey="Ozcinar B" first="Beyza" last="Ozcinar">Beyza Ozcinar</name><affiliation wicri:level="1"><nlm:affiliation>Istanbul University, Istanbul Medical Faculty, General Surgery Department, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Istanbul University, Istanbul Medical Faculty, General Surgery Department, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Guler, Sertac Ata" sort="Guler, Sertac Ata" uniqKey="Guler S" first="Sertac Ata" last="Guler">Sertac Ata Guler</name></author><author><name sortKey="Kocaman, Nazmiye" sort="Kocaman, Nazmiye" uniqKey="Kocaman N" first="Nazmiye" last="Kocaman">Nazmiye Kocaman</name></author><author><name sortKey="Ozkan, Mine" sort="Ozkan, Mine" uniqKey="Ozkan M" first="Mine" last="Ozkan">Mine Ozkan</name></author><author><name sortKey="Gulluoglu, Bahadir M" sort="Gulluoglu, Bahadir M" uniqKey="Gulluoglu B" first="Bahadir M" last="Gulluoglu">Bahadir M. Gulluoglu</name></author><author><name sortKey="Ozmen, Vahit" sort="Ozmen, Vahit" uniqKey="Ozmen V" first="Vahit" last="Ozmen">Vahit Ozmen</name></author></analytic><series><title level="j">Breast (Edinburgh, Scotland)</title><idno type="eISSN">1532-3080</idno><imprint><date when="2012" type="published">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Breast Neoplasms (epidemiology)</term><term>Breast Neoplasms (pathology)</term><term>Breast Neoplasms (surgery)</term><term>Cohort Studies</term><term>Disease-Free Survival</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Incidence</term><term>Lymph Node Excision (adverse effects)</term><term>Lymph Node Excision (statistics & numerical data)</term><term>Lymphedema (epidemiology)</term><term>Lymphedema (etiology)</term><term>Lymphedema (pathology)</term><term>Middle Aged</term><term>Neoplasm Staging</term><term>Prospective Studies</term><term>Risk Factors</term><term>Sentinel Lymph Node Biopsy (adverse effects)</term><term>Sentinel Lymph Node Biopsy (statistics & numerical data)</term><term>Severity of Illness Index</term><term>Turkey</term><term>Women's Health</term><term>Young Adult</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Biopsie de noeud lymphatique sentinelle ()</term><term>Biopsie de noeud lymphatique sentinelle (effets indésirables)</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Incidence</term><term>Indice de gravité médicale</term><term>Jeune adulte</term><term>Lymphadénectomie ()</term><term>Lymphadénectomie (effets indésirables)</term><term>Lymphoedème (anatomopathologie)</term><term>Lymphoedème (épidémiologie)</term><term>Lymphoedème (étiologie)</term><term>Santé des femmes</term><term>Stade de la tumeur</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Survie sans rechute</term><term>Tumeurs du sein ()</term><term>Tumeurs du sein (anatomopathologie)</term><term>Tumeurs du sein (épidémiologie)</term><term>Turquie</term><term>Études de cohortes</term><term>Études de suivi</term><term>Études prospectives</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Turkey</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lymph Node Excision</term><term>Sentinel Lymph Node Biopsy</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Lymphoedème</term><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Biopsie de noeud lymphatique sentinelle</term><term>Lymphadénectomie</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Breast Neoplasms</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Breast Neoplasms</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Lymph Node Excision</term><term>Sentinel Lymph Node Biopsy</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Lymphoedème</term><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Cohort Studies</term><term>Disease-Free Survival</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Incidence</term><term>Middle Aged</term><term>Neoplasm Staging</term><term>Prospective Studies</term><term>Risk Factors</term><term>Severity of Illness Index</term><term>Women's Health</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Biopsie de noeud lymphatique sentinelle</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Incidence</term><term>Indice de gravité médicale</term><term>Jeune adulte</term><term>Lymphadénectomie</term><term>Santé des femmes</term><term>Stade de la tumeur</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Survie sans rechute</term><term>Tumeurs du sein</term><term>Turquie</term><term>Études de cohortes</term><term>Études de suivi</term><term>Études prospectives</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Turquie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Lymphedema, a sequela of breast cancer and breast cancer therapy, changes functional abilities and may affect a patient's psychosocial adjustment and overall quality of life. Aim of this prospective observational study was to determine the rate of mid-term and late time period lymphedema in breast cancer patients with different loco-regional treatments, and factors associated with lymphedema.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22460058</PMID><DateCreated><Year>2012</Year><Month>06</Month><Day>19</Day></DateCreated><DateCompleted><Year>2012</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2012</Year><Month>06</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-3080</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>3</Issue><PubDate><Year>2012</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Breast (Edinburgh, Scotland)</Title><ISOAbbreviation>Breast</ISOAbbreviation></Journal><ArticleTitle>Breast cancer related lymphedema in patients with different loco-regional treatments.</ArticleTitle><Pagination><MedlinePgn>361-5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.breast.2012.03.002</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Lymphedema, a sequela of breast cancer and breast cancer therapy, changes functional abilities and may affect a patient's psychosocial adjustment and overall quality of life. Aim of this prospective observational study was to determine the rate of mid-term and late time period lymphedema in breast cancer patients with different loco-regional treatments, and factors associated with lymphedema.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Patients surgically treated for early-stage breast cancer were prospectively enrolled in the study. Demographic, clinical, pathological, and loco-regional treatments data of patients and lymphedema rates were recorded. Patients were divided into six groups regarding different loco-regional treatments. Pre- and postoperative (12 months, and median 64 months after surgery) circumferences of arms were recorded.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">218 patients, all female with a median age of 48 (19-82) years, were included in the study. The numbers of patients in breast conservation surgery group (BCS) (N=104), mastectomy group (N=114), sentinel lymph node biopsy group (SLNB) (N=80), axillary lymph node dissection group (ALND) (N=138), group with radiotherapy (RT) (N=88) and group without radiotherapy (N=130). Incidence of lymphedema after surgery in mid-term period was 24.8%. The rate of lymphedema at 64 months median follow-up time was 7.3%. (BCS: 11.1%, 4.2% and 0.5%; Mastectomy: 15.0%, 3.2% and 1.4%; SLNB: 8.0%, 1.9% and 0.5%; ALND: 18.0%, 5.3% and 1.4%; RT: 14.7%, 6.3% and 1.4%; without RT: 11.4%, 2.1% and 0.5%). When we excluded patients with both mid-term and late term lymphedema, only four patients developed lymphedema at late time, then re-calculated late term lypmhedema rate was 1.8%. The factors affecting the lymphedema was ALND and radiotherapy (RT) and no lymphedema was detected in patients underwent breast conserving surgery and SLNB. Age and body mass index were not related to lymphedema at any time.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The incidence of lymphedema gradually increased in time and a quarter of patients experienced the complication at the end of year. The rate of lymphedema in patients with ALND was significantly higher than patients with SLNB alone. If RT added to SLNB the lymphedema rate was getting higher than SLNB alone. In all patients lymphedema rate was decreased one year after the surgery and further decreased at median 64 months follow-up time period.</AbstractText><CopyrightInformation>Copyright © 2012 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ozcinar</LastName><ForeName>Beyza</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Istanbul University, Istanbul Medical Faculty, General Surgery Department, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guler</LastName><ForeName>Sertac Ata</ForeName><Initials>SA</Initials></Author><Author ValidYN="Y"><LastName>Kocaman</LastName><ForeName>Nazmiye</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Ozkan</LastName><ForeName>Mine</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Gulluoglu</LastName><ForeName>Bahadir M</ForeName><Initials>BM</Initials></Author><Author ValidYN="Y"><LastName>Ozmen</LastName><ForeName>Vahit</ForeName><Initials>V</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>03</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Breast</MedlineTA><NlmUniqueID>9213011</NlmUniqueID><ISSNLinking>0960-9776</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021701" MajorTopicYN="N">Sentinel Lymph Node Biopsy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="Y">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014421" MajorTopicYN="N" Type="Geographic">Turkey</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016387" MajorTopicYN="N">Women's Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>04</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2012</Year><Month>02</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>03</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22460058</ArticleId><ArticleId IdType="pii">S0960-9776(12)00061-6</ArticleId><ArticleId IdType="doi">10.1016/j.breast.2012.03.002</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Turquie</li></country></list><tree><noCountry><name sortKey="Guler, Sertac Ata" sort="Guler, Sertac Ata" uniqKey="Guler S" first="Sertac Ata" last="Guler">Sertac Ata Guler</name><name sortKey="Gulluoglu, Bahadir M" sort="Gulluoglu, Bahadir M" uniqKey="Gulluoglu B" first="Bahadir M" last="Gulluoglu">Bahadir M. Gulluoglu</name><name sortKey="Kocaman, Nazmiye" sort="Kocaman, Nazmiye" uniqKey="Kocaman N" first="Nazmiye" last="Kocaman">Nazmiye Kocaman</name><name sortKey="Ozkan, Mine" sort="Ozkan, Mine" uniqKey="Ozkan M" first="Mine" last="Ozkan">Mine Ozkan</name><name sortKey="Ozmen, Vahit" sort="Ozmen, Vahit" uniqKey="Ozmen V" first="Vahit" last="Ozmen">Vahit Ozmen</name></noCountry><country name="Turquie"><noRegion><name sortKey="Ozcinar, Beyza" sort="Ozcinar, Beyza" uniqKey="Ozcinar B" first="Beyza" last="Ozcinar">Beyza Ozcinar</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002141 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002141 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:22460058
|texte= Breast cancer related lymphedema in patients with different loco-regional treatments.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:22460058" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |